DNA origami as a carrier for circumvention of drug resistance.

Although a multitude of promising anti-cancer drugs have been developed over the past 50 years, effective delivery of the drugs to diseased cells remains a challenge. Recently, nanoparticles have been used as drug delivery vehicles due to their high delivery efficiencies and the possibility to circumvent cellular drug resistance. However, the lack of biocompatibility and inability to engineer spatially addressable surfaces for multi-functional activity remains an obstacle to their widespread use. Here we present a novel drug carrier system based on self-assembled, spatially addressable DNA origami nanostructures that confronts these limitations. Doxorubicin, a well-known anti-cancer drug, was non-covalently attached to DNA origami nanostructures through intercalation. A high level of drug loading efficiency was achieved, and the complex exhibited prominent cytotoxicity not only to regular human breast adenocarcinoma cancer cells (MCF 7), but more importantly to doxorubicin-resistant cancer cells, inducing a remarkable reversal of phenotype resistance. With the DNA origami drug delivery vehicles, the cellular internalization of doxorubicin was increased, which contributed to the significant enhancement of cell-killing activity to doxorubicin-resistant MCF 7 cells. Presumably, the activity of doxorubicin-loaded DNA origami inhibits lysosomal acidification, resulting in cellular redistribution of the drug to action sites. Our results suggest that DNA origami has immense potential as an efficient, biocompatible drug carrier and delivery vehicle in the treatment of cancer.

[1]  G. Hortobagyi,et al.  Anthracyclines in the Treatment of Cancer , 2012, Drugs.

[2]  Daniel G. Anderson,et al.  Molecularly Self-Assembled Nucleic Acid Nanoparticles for Targeted In Vivo siRNA Delivery , 2012, Nature nanotechnology.

[3]  Shawn M. Douglas,et al.  A Logic-Gated Nanorobot for Targeted Transport of Molecular Payloads , 2012, Science.

[4]  Robert Langer,et al.  Nanoparticle delivery of cancer drugs. , 2012, Annual review of medicine.

[5]  Hao Yan,et al.  Challenges and opportunities for structural DNA nanotechnology. , 2011, Nature nanotechnology.

[6]  Tim Liedl,et al.  Cellular immunostimulation by CpG-sequence-coated DNA origami structures. , 2011, ACS nano.

[7]  H. Pei,et al.  Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides. , 2011, ACS nano.

[8]  Dong-Ming Huang,et al.  Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy. , 2011, ACS nano.

[9]  Hao Yan,et al.  Site-specific synthesis and in situ immobilization of fluorescent silver nanoclusters on DNA nanoscaffolds by use of the Tollens reaction. , 2011, Angewandte Chemie.

[10]  Hao Yan,et al.  DNA Origami with Complex Curvatures in Three-Dimensional Space , 2011, Science.

[11]  D. Meldrum,et al.  Stability of DNA origami nanoarrays in cell lysate. , 2011, Nano letters.

[12]  Hao Yan,et al.  Interconnecting gold islands with DNA origami nanotubes. , 2010, Nano letters.

[13]  M. Stevens,et al.  Engineering nanocomposite materials for cancer therapy. , 2010, Small.

[14]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[15]  D. Ingber,et al.  Self-assembly of 3D prestressed tensegrity structures from DNA , 2010, Nature nanotechnology.

[16]  Hao Yan,et al.  DNA-origami-directed self-assembly of discrete silver-nanoparticle architectures. , 2010, Angewandte Chemie.

[17]  Wael Mamdouh,et al.  Single-molecule chemical reactions on DNA origami. , 2010, Nature nanotechnology.

[18]  Hao Yan,et al.  Gold nanoparticle self-similar chain structure organized by DNA origami. , 2010, Journal of the American Chemical Society.

[19]  Shawn M. Douglas,et al.  Folding DNA into Twisted and Curved Nanoscale Shapes , 2009, Science.

[20]  J. Kjems,et al.  Self-assembly of a nanoscale DNA box with a controllable lid , 2009, Nature.

[21]  Shawn M. Douglas,et al.  Self-assembly of DNA into nanoscale three-dimensional shapes , 2009, Nature.

[22]  Eun Seong Lee,et al.  Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH. , 2008, Small.

[23]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[24]  James R Heath,et al.  Nanotechnology and cancer. , 2008, Annual review of medicine.

[25]  Russell P. Goodman,et al.  A self-assembled DNA bipyramid. , 2007, Journal of the American Chemical Society.

[26]  P. Rothemund.  Folding DNA to create nanoscale shapes and patterns , 2006, Nature.

[27]  Theresa M Allen,et al.  Anti-CD19-Targeted Liposomal Doxorubicin Improves the Therapeutic Efficacy in Murine B-Cell Lymphoma and Ameliorates the Toxicity of Liposomes with Varying Drug Release Rates , 2005, Clinical Cancer Research.

[28]  Andrew J Turberfield,et al.  The single-step synthesis of a DNA tetrahedron. , 2004, Chemical communications.

[29]  Yan Liu,et al.  DNA-Templated Self-Assembly of Protein Arrays and Highly Conductive Nanowires , 2003, Science.

[30]  You Han Bae,et al.  Polymeric micelle for tumor pH and folate-mediated targeting. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[31]  E. Arriaga,et al.  Detection of doxorubicin and metabolites in cell extracts and in single cells by capillary electrophoresis with laser-induced fluorescence detection. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[32]  M. Gottesman.  Mechanisms of cancer drug resistance. , 2002, Annual review of medicine.

[33]  J. Reif,et al.  Construction, analysis, ligation, and self-assembly of DNA triple crossover complexes , 2000 .

[34]  D. Tzemach,et al.  Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models. , 1999, Anti-cancer drugs.

[35]  S. Simon,et al.  Tamoxifen inhibits acidification in cells independent of the estrogen receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  N. Seeman,et al.  Design and self-assembly of two-dimensional DNA crystals , 1998, Nature.

[37]  C. Slapak,et al.  Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes. , 1997, Blood.

[38]  S. Simon,et al.  Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7adr). , 1996, Biochemistry.

[39]  C. Higgins,et al.  Drug efflux mediated by the human multidrug resistance P-glycoprotein is inhibited by cell swelling. , 1994, Journal of cell science.

[40]  S. Wadler,et al.  Phase I and II Agents in Cancer Therapy: Two Cisplatin Analogues and High‐Dose Cisplatin in Hypertonic Saline or With Thiosulfate Protection , 1987, Journal of clinical pharmacology.

[41]  N. Seeman.  Nucleic acid junctions and lattices. , 1982, Journal of theoretical biology.

[42]  M. Dalmark,et al.  A Fickian diffusion transport process with features of transport catalysis. Doxorubicin transport in human red blood cells , 1981, The Journal of general physiology.

[43]  W. Pigram,et al.  Stereochemistry of intercalation: interaction of daunomycin with DNA. , 1972, Nature: New biology.